Cyclacel removes preferred stock ownership caps and increases authorized shares to 250M

Bio Green Med Solution, Inc.

Stockholders removed Series C and D convertible preferred stock ownership limitations, eliminating conversion caps.
Authorized common shares increased from 100M to 250M; charter amendment filed Feb 10, 2025.
David Lazar received 2.1M Series D preferred shares after Series D amendment removal of the 49.99% cap.
Series C amendment removed 5% ownership limit; Series D removed 49.99% limit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.